Your session is about to expire
← Back to Search
Probiotic
Probiotic Arm for Alcohol Use Disorder
Phase 2
Waitlist Available
Led By Mollie Monnig, PhD
Research Sponsored by Brown University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 30 days
Awards & highlights
Study Summary
This trial will study if probiotics can help reduce liver damage in heavy drinkers who don't seek treatment.
Eligible Conditions
- Alcohol Use Disorder
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 30 days
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~30 days
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
interleukin-6 (IL-6)
lipopolysaccharide binding protein (LBP)
monocyte chemoattractant protein-1 (MCP-1)
+3 moreTrial Design
1Treatment groups
Experimental Treatment
Group I: Probiotic ArmExperimental Treatment1 Intervention
Probiotic arm
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Seed DS-01 Daily Synbiotic
2022
Completed Phase 2
~40
Find a Location
Who is running the clinical trial?
Brown UniversityLead Sponsor
456 Previous Clinical Trials
563,050 Total Patients Enrolled
National Institute on Alcohol Abuse and Alcoholism (NIAAA)NIH
799 Previous Clinical Trials
1,362,480 Total Patients Enrolled
Mollie Monnig, PhDPrincipal InvestigatorBrown University
1 Previous Clinical Trials
70 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger